Copiktra

Active Ingredient(s): Duvelisib
FDA Approved: * September 24, 2018
Pharm Company: * VERASTEM INC
Category: Cancer

Duvelisib, sold under the brand name Copiktra, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma after other treatments have failed.[3] It is taken by mouth.[3] Common side effects include diarrhea, low white blood cells, rash, feeling tired, fever, and muscle pains.[3] Other serious side effects include inflammation of the lungs and infections.[3] It is a ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Copiktra 15 mg Oral Capsule
NDC: 71779-115
Labeler:
Verastem, Inc.
Copiktra 25 mg Oral Capsule
NDC: 71779-125
Labeler:
Verastem, Inc.
Copiktra 15 mg Oral Capsule
NDC: 73116-215
Labeler:
Secura Bio, Inc.
Copiktra 25 mg Oral Capsule
NDC: 73116-225
Labeler:
Secura Bio, Inc.